HESI LPN
HESI PN Nutrition Practice Exam
1. What is a common treatment for a child with moderate to severe eczema?
- A. Topical corticosteroids
- B. Oral antibiotics
- C. Frequent saline irrigation
- D. High-calcium diet
Correct answer: A
Rationale: Topical corticosteroids are the correct answer for a child with moderate to severe eczema. These medications are commonly used to reduce inflammation and itching associated with eczema. Oral antibiotics (Choice B) are not typically used in eczema treatment unless there is a secondary bacterial infection. Frequent saline irrigation (Choice C) may aid in wound care but is not a primary treatment for eczema. A high-calcium diet (Choice D) is not a standard treatment for eczema and does not target the underlying inflammatory process that causes eczema symptoms.
2. How should the healthcare provider respond to a parent concerned about a child's short stature?
- A. Suggest the parent consult a nutritionist
- B. Recommend frequent growth hormone injections
- C. Advise monitoring for a few years before intervention
- D. Refer for a genetic evaluation
Correct answer: C
Rationale: When a parent expresses concern about a child's short stature, the initial approach should involve advising monitoring for a few years before considering any interventions. This allows for observation of the child's growth pattern and any potential underlying issues. Suggesting a nutritionist (Choice A) may not be necessary if there are no signs of nutritional deficiencies. Recommending growth hormone injections (Choice B) is premature without proper evaluation and diagnosis. Referring for a genetic evaluation (Choice D) can be considered later if monitoring shows atypical growth patterns or other concerning factors.
3. What is a common clinical manifestation of Kawasaki disease?
- A. Severe headaches
- B. High fever lasting more than 5 days
- C. Chronic cough
- D. Severe abdominal pain
Correct answer: B
Rationale: A high fever lasting more than 5 days is a common clinical manifestation of Kawasaki disease. This fever is often accompanied by other symptoms such as rash and conjunctivitis. Severe headaches (Choice A), chronic cough (Choice C), and severe abdominal pain (Choice D) are not typically associated with Kawasaki disease, making them incorrect choices.
4. What is a common side effect of corticosteroid therapy in children?
- A. Increased appetite
- B. Decreased blood glucose levels
- C. Inhibited growth
- D. Mood changes
Correct answer: A
Rationale: The correct answer is A: Increased appetite. Corticosteroid therapy commonly causes increased appetite in children. This side effect can lead to weight gain and other metabolic changes. Option B is incorrect because corticosteroid therapy is more likely to result in increased blood glucose levels. Option C is incorrect because corticosteroid therapy can inhibit growth due to its impact on the endocrine system. Option D is incorrect because corticosteroid therapy can lead to mood changes such as irritability or even mood swings rather than improved mood.
5. What is an important aspect of the care plan for a child with eczema?
- A. Use of steroid creams
- B. Frequent antibiotic therapy
- C. High-protein diet
- D. Daily baths in hot water
Correct answer: A
Rationale: The correct answer is A: Use of steroid creams. Steroid creams are commonly used in the management of eczema to reduce inflammation and itching, thus improving the skin condition and comfort of the child. Choice B, frequent antibiotic therapy, is incorrect as antibiotics are not typically used to treat eczema unless there is a secondary bacterial infection. Choice C, a high-protein diet, is not a specific recommendation for eczema treatment. Choice D, daily baths in hot water, is not recommended for eczema care as hot water can exacerbate the condition by drying out the skin.
Similar Questions
Access More Features
HESI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access